GRAIL (GRAL) Stock Forecast, Price Target & Predictions
GRAL Stock Forecast
GRAIL (GRAL) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $106.14, with a high of $175.00 and a low of $56.00. This represents a -22.68% decline from the last price of $137.28.
GRAL Stock Rating
GRAIL stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (62.50%), 3 Hold (37.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).
Buy
GRAL Price Target Upside V Benchmarks
| Type | Name | Upside |
|---|---|---|
| Stock | GRAIL | -22.68% |
| Sector | Healthcare Stocks | 15.45% |
| Industry | Diagnostics & Research Stocks | 2.88% |
Price Target Trends
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 7 | 8 | 21 |
| Avg Price Target | $116.57 | $110.13 | $92.33 |
| Last Closing Price | $137.28 | $137.28 | $137.28 |
| Upside/Downside | -15.09% | -19.78% | -32.74% |
Ratings Trends
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
|---|---|---|---|---|---|---|
| Oct, 26 | - | 5 | 6 | - | - | 11 |
| Sep, 26 | - | 4 | 5 | - | - | 9 |
| Aug, 26 | - | 4 | 5 | - | - | 9 |
| Jul, 26 | - | 4 | 5 | - | - | 9 |
| Jun, 26 | - | 4 | 4 | - | - | 8 |
Analyst Price Target Forecasts
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 02, 2026 | UBS | $175.00 | $137.72 | 27.07% | 27.48% | |
| Sep 28, 2026 | Kyle Mikson | Canaccord Genuity | $150.00 | $126.89 | 18.21% | 9.27% |
| Sep 25, 2026 | Bradley Bowers | Mizuho Securities | $100.00 | $125.21 | -20.13% | -27.16% |
| Sep 22, 2026 | Robert Bamberger | Robert W. Baird | $118.00 | $107.97 | 9.29% | -14.04% |
| Sep 17, 2026 | UBS | $84.00 | $75.11 | 11.84% | -38.81% | |
| Sep 17, 2026 | Dan Leonard | RBC Capital | $84.00 | $75.11 | 11.84% | -38.81% |
| Sep 09, 2026 | UBS | $105.00 | $79.10 | 32.74% | -23.51% | |
| Jul 15, 2026 | Mizuho Securities | $65.00 | $73.12 | -11.11% | -52.65% | |
| Jun 05, 2026 | Evie Koslosky | Goldman Sachs | $60.00 | $66.55 | -9.84% | -56.29% |
| May 06, 2026 | Piper Sandler | $56.00 | $54.40 | 2.94% | -59.21% |
Analyst Rating Forecasts
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 02, 2026 | UBS | Buy | Buy | hold |
| Sep 24, 2026 | Cowen & Co. | Buy | Buy | hold |
| Sep 17, 2026 | RBC Capital | Sector Perform | initialise | |
| Sep 09, 2026 | UBS | Buy | initialise | |
| Jul 15, 2026 | Cowen & Co. | Buy | Buy | hold |
| Jun 05, 2026 | Goldman Sachs | Neutral | initialise | |
| May 06, 2026 | Cowen & Co. | Buy | Buy | hold |
| May 06, 2026 | Piper Sandler | Neutral | Neutral | hold |
| Apr 10, 2026 | Piper Sandler | Neutral | initialise | |
| Feb 20, 2026 | Cowen & Co. | Hold | Hold | hold |
Financial Forecast
EPS Forecast
Annual
| Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|
| Reported | $-63.54 | $-11.11 | - | - |
| Avg Forecast | $-65.16 | $-15.15 | $-13.81 | $-12.39 |
| High Forecast | $-62.42 | $-14.51 | $-12.95 | $-11.87 |
| Low Forecast | $-69.26 | $-16.10 | $-14.67 | $-13.17 |
| Surprise % | -2.49% | -26.67% | - | - |
Revenue Forecast
Annual
| Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|
| Reported | $125.59M | $147.17M | - | - |
| Avg Forecast | $122.67M | $139.62M | $161.50M | $189.90M |
| High Forecast | $128.60M | $146.37M | $169.31M | $199.09M |
| Low Forecast | $118.71M | $135.11M | $156.28M | $183.76M |
| Surprise % | 2.38% | 5.41% | - | - |
Net Income Forecast
Annual
| Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|
| Reported | $-2.03B | $-408.35M | - | - |
| Avg Forecast | $-2.12B | $-475.36M | $-428.84M | $-388.76M |
| High Forecast | $-1.94B | $-450.68M | $-402.13M | $-368.58M |
| Low Forecast | $-2.15B | $-500.03M | $-455.54M | $-408.94M |
| Surprise % | -4.27% | -14.10% | - | - |